ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer

BACKGROUND: We recently showed that the presence of ERCC1(+)CTCs is an independent predictive biomarker for platinum-resistance and poor prognosis of ovarian cancer. The goal of our current research was to determine how the auxiliary assessment of ERCC1-transcripts influences overall CTC-detection r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chebouti, Issam, Kuhlmann, Jan Dominik, Buderath, Paul, Weber, Stephan, Wimberger, Pauline, Bokeloh, Yvonne, Hauch, Siegfried, Kimmig, Rainer, Kasimir-Bauer, Sabine
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5421848/
https://ncbi.nlm.nih.gov/pubmed/28388557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados